TeamHealth Announces Leadership Transition

Go back to TeamHealth Announces Leadership Transition

Jefferies Reiterates Buy on TeamHealth Holdings (TMH) Following CEO Appointment

September 7, 2016 8:45 AM EDT

Jefferies reiterated a Buy rating and $47.00 price target on TeamHealth Holdings (NYSE: TMH) following the company's appointment of Leif Murphy as President & CEO. Given the CEO appointment, Jefferies views the potential sale of TMH as unlikely in the near-term, and believes that TMH's recent... More